The Profile of the Depression and it's Intervention Strategy in Patients With Parkinson's Disease in China
1 other identifier
observational
500
1 country
4
Brief Summary
Depression is considered to be the most common neuropsychiatric disturbance of PD. In this study, investigators will summarize the treatment profile of PD depression to see if PD depression is properly treated according to guideline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 11, 2017
CompletedFirst Posted
Study publicly available on registry
January 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedMay 11, 2018
May 1, 2018
1.9 years
January 11, 2017
May 6, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
The incidence of depression in patients of Parkinson's disease (DSM-5 diagnostic criteria for depression)
through study completion, an average of 1 year
Interventions
no intervention
Eligibility Criteria
The estimated proportion of depression in patients with PD is around 50%. With 500 patients, the length of 95% CI of proportion of depression in PD patients will be less than 0.09 (the widest 95% confidence interval 0.088 will be attained only when the estimated proportion is 50%).
You may qualify if:
- The incidence of depression in patients of Parkinson's disease (DSM-5 diagnostic criteria for depression)
You may not qualify if:
- Inability to understand or answer questions for any reason，that would interfere our assessment.
- Participate in a concurrent clinical trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Department of Neurology,Nanjing Brain Hospital,Nanjing Medical University
Nanjing, China
Department of Neurology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Shanghai, China
Department of Neurology, Shanghai Tongji Hospital, Tongji University School of Medicine
Shanghai, China
Zhongshan Hospital & Shanghai Medical College, Fudan University
Shanghai, China
Related Publications (1)
Gan J, Zhou M, Chen W, Liu Z. Non-motor symptoms in Chinese Parkinson's disease patients. J Clin Neurosci. 2014 May;21(5):751-4. doi: 10.1016/j.jocn.2013.07.015. Epub 2013 Sep 11.
PMID: 24411328BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhenguo Liu
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2017
First Posted
January 20, 2017
Study Start
January 1, 2017
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
May 11, 2018
Record last verified: 2018-05